Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of injection solution on the resection status of colonic polyps
DRKS00012741Phase 4Recruiting
- Sponsor
- University Hospital Würzburg
- Start
- Jul 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Glycerosteril, sodium chloride, indigotindisulfonate sodium and epinephrine in colon adenoma (2 arms), sponsored by University Hospital Würzburg. Primary endpoint: Complete resection rate based on histologic assessment of resection margins. Started Jul 2017; status: recruiting.
02
Drugs
Glycerosterilsodium chlorideindigotindisulfonate sodiumepinephrine
03
Conditions
colon adenoma
Beyond the preview
Go deeper on DRKS00012741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012741.